NAD+ 500mg

Nicotinamide Adenine Dinucleotide is the research community's shorthand for NAD+ - the same compound listed on this page. If you searched for Nicotinamide Adenine Dinucleotide, NAD Plus, NAD+ Peptide, this is that compound: NAD+ supplied as a 500mg lyophilised vial with batch-specific analytical documentation in progress at Janoshik Analytical. For in-vitro research use only.

NAD+ is a synthetic peptide supplied by Pillar Research as Lyophilised research material for lawful in-vitro laboratory research under the Research Use Only (RUO) framework. In research communities it is also searched for as NAD Plus, NAD+ Peptide - all refer to the same compound.

Studied for how cells produce and use energy. More precisely, a coenzyme central to cellular energy metabolism, studied for its role in mitochondrial function rather than through any single peptide-receptor pathway. NAD+ is supplied strictly as Research Use Only material for in-vitro laboratory work.

Studied for how cells produce energy and how mitochondria behave. More precisely, cellular energy metabolism, mitochondrial function, and research into ageing-related and cognitive processes.

NAD+ is commonly referred to as Nicotinamide Adenine Dinucleotide in research communities and is sometimes searched for as NAD Plus, NAD+ Peptide - all refer to the same compound.

NAD+ is also referenced by its historical name "cozymase". It is distinct from NADH, the reduced form of the same coenzyme, which is a chemically different molecule with its own separate research literature.

You are looking at the evidence the same way researchers do: by compound, batch and method, not by marketing claim. NAD+ is supplied as a research-use compound for lawful in-vitro laboratory research under the Research Use Only (RUO) framework. Batch-specific analytical documentation, including identity and purity results, is in progress at Janoshik Analytical.

Pillar Research does not provide dosing, reconstitution-for-use, or administration guidance for any compound - this is a deliberate policy, not an oversight, consistent with the Research Use Only framework under which NAD+ is supplied. Research protocols vary by study design and institution. Consult the peer-reviewed literature for the compound (see the references linked on this page) or a qualified research supervisor for protocol-specific guidance.

NAD+ (500mg) is available through Pillar Research, a trusted supplier for research peptides, with fast domestic shipping to all states and territories. Every vial is dispatched from domestic Australian stock the same business day - no customs delays, no international freight uncertainty. Batch-specific analytical documentation is in progress at Janoshik Analytical. See our supplier guide at /buy-peptides-australia for the checklist to apply to any Australian supplier.

Pillar Research does. A batch-specific Certificate of Analysis for NAD+ from Janoshik Analytical, an independent third-party laboratory, is in progress and will be published before dispatch. Stock is held in Australia and dispatched with dispatch in an estimated 1-2 weeks.

NAD+ (500mg) is priced at A$119.99 per vial at Pillar Research. NAD+ is open for preorder now. Orders dispatch in an estimated 1-2 weeks, once the batch and its Certificate of Analysis are ready. Pricing includes batch-specific analytical documentation.

NAD+ is a research-use compound supplied for lawful in-vitro laboratory research under the Research Use Only (RUO) framework. Purchasers confirm the compound is intended for in-vitro research use at checkout.

Ordering is straightforward - add NAD+ 500mg (Nicotinamide Adenine Dinucleotide) to your cart on this page and complete checkout. All orders are fulfilled from domestic Australian stock and shipped with tracking; dispatch in an estimated 1-2 weeks. Batch-specific analytical documentation is in progress at Janoshik Analytical.

Yes. A batch-specific Certificate of Analysis (COA) for NAD+ 500mg (Nicotinamide Adenine Dinucleotide) is in progress at Janoshik Analytical and will be included with dispatch. NAD+ 500mg (Nicotinamide Adenine Dinucleotide) will have its batch-specific purity and identity results in progress at Janoshik Analytical.

Published research observes declining NAD+ levels with age and studies several contributing mechanisms, including increased consumption by age-related cellular processes. This observed decline is why NAD+ features in mitochondrial and ageing-marker research. Pillar Research supplies NAD+ strictly as Research Use Only material for in-vitro laboratory work.

No. NAD+ is not listed on the Australian Register of Therapeutic Goods (ARTG), so it is not stocked by Australian retail pharmacies and is not a therapeutic good under the Therapeutic Goods Act 1989 (Cth). Compounding pharmacies cannot supply it either - there is no approved commercial or pharmacy release to compound from. Pillar Research supplies it as Research Use Only material for in-vitro laboratory work, not for human or animal use, and it should not be sought as a consumer product.

NAD+ may be lawfully supplied and held in Australia as Research Use Only material for in-vitro laboratory and educational research. That is a different status from approval for human use, which it does not have. Purchasers confirm they are a qualified researcher or acting for a licensed research facility, and are responsible for the lawful handling, storage and use of the material.